본문바로가기
Q
U
I
C
K

Business

SK bioscience’s effort reaches beyond the development and manufacture of its own premium vaccines
and extends to working with domestic and overseas partners to create a healthy future for mankind.

In-house Products

SK bioscience develops vaccine products through its innovative technology and produces them with a strict quality control system.
The world’s first quadrivalent cell culture-derived influenza vaccine

SKY Cellflu Quadrivalent prefilled syringe

(Cell-cultured Influenza Vaccine)

SKY Cellflu Quadrivalent prefilled syringe image
Cell culture-derived influenza vaccine with SK Bioscience’s technology

SKY Cellflu prefilled syringe

(Cell-cultured Influenza Vaccine)

SKY Cellflu prefilled syringe image
New solution for preventing shingles developed by SK Bioscience

SKY Zoster Inj

SKY Zoster Inj image
New solution for preventing chicken pox developed by SK Bioscience

SKY Varicella Inj.

SKY Varicella Inj. image
Learn about SK Bioscience’s In-house products in Pipeline today